Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech ...

Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, ...

Researchers evaluated potential associations between semaglutide exposure and ischemic optic neuropathy across various formulations and patient subgroups.

Amazon will now help its customers lose weight. The company will be providing GLP-1 treatments for weight loss through its ...

Alcohol intake rates frequently fall after traumatic events, such as the AIDS epidemic in 1981 and now after the COVID-19 ...

Amazon’s wants to start delivering GLP-1 drugs ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

Amazon launched a new program aimed at expanding access to popular GLP-1 weight-loss drugs. The initiative, through Amazon ...

The new offering combines primary care, personalized treatment plans and transparent medication costs to help patients ...

Eli Lilly most recent acquisition shows its aspirations beyond weight loss drugs. There’s time for investors to get in and ...

The company argues the offering is a more comprehensive approach to weight management, allowing patients to receive ongoing ...

Adults who use a GLP-1 have lower macronutrient intake than nonusers, according to data that will be presented at the ...